119 related articles for article (PubMed ID: 12686427)
1. Caspase-3 activation and ERK phosphorylation during CVB3 infection of cells: influence of the coxsackievirus and adenovirus receptor and engineered variants.
Cunningham KA; Chapman NM; Carson SD
Virus Res; 2003 Apr; 92(2):179-86. PubMed ID: 12686427
[TBL] [Abstract][Full Text] [Related]
2. ERK MAP kinase-activated Arf6 trafficking directs coxsackievirus type B3 into an unproductive compartment during virus host-cell entry.
Marchant D; Sall A; Si X; Abraham T; Wu W; Luo Z; Petersen T; Hegele RG; McManus BM
J Gen Virol; 2009 Apr; 90(Pt 4):854-862. PubMed ID: 19264606
[TBL] [Abstract][Full Text] [Related]
3. A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells.
Shafren DR; Williams DT; Barry RD
J Virol; 1997 Dec; 71(12):9844-8. PubMed ID: 9371658
[TBL] [Abstract][Full Text] [Related]
4. Variations of coxsackievirus B3 capsid primary structure, ligands, and stability are selected for in a coxsackievirus and adenovirus receptor-limited environment.
Carson SD; Chapman NM; Hafenstein S; Tracy S
J Virol; 2011 Apr; 85(7):3306-14. PubMed ID: 21270163
[TBL] [Abstract][Full Text] [Related]
5. Endogenous low-level expression of the coxsackievirus and adenovirus receptor enables coxsackievirus B3 infection of RD cells.
Carson SD; Kim KS; Pirruccello SJ; Tracy S; Chapman NM
J Gen Virol; 2007 Nov; 88(Pt 11):3031-3038. PubMed ID: 17947527
[TBL] [Abstract][Full Text] [Related]
6. Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway.
Luo H; Yanagawa B; Zhang J; Luo Z; Zhang M; Esfandiarei M; Carthy C; Wilson JE; Yang D; McManus BM
J Virol; 2002 Apr; 76(7):3365-73. PubMed ID: 11884562
[TBL] [Abstract][Full Text] [Related]
7. The Coxsackievirus and Adenovirus Receptor: Glycosylation and the Extracellular D2 Domain Are Not Required for Coxsackievirus B3 Infection.
Pinkert S; Röger C; Kurreck J; Bergelson JM; Fechner H
J Virol; 2016 Jun; 90(12):5601-5610. PubMed ID: 27030267
[TBL] [Abstract][Full Text] [Related]
8. Heparan sulfates and coxsackievirus-adenovirus receptor: each one mediates coxsackievirus B3 PD infection.
Zautner AE; Körner U; Henke A; Badorff C; Schmidtke M
J Virol; 2003 Sep; 77(18):10071-7. PubMed ID: 12941917
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase B/Akt regulates coxsackievirus B3 replication through a mechanism which is not caspase dependent.
Esfandiarei M; Luo H; Yanagawa B; Suarez A; Dabiri D; Zhang J; McManus BM
J Virol; 2004 Apr; 78(8):4289-98. PubMed ID: 15047842
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of two coxsackievirus B3 strains: putative influence of virus-receptor interactions on pathogenesis.
Selinka HC; Wolde A; Pasch A; Klingel K; Schnorr JJ; Küpper JH; Lindberg AM; Kandolf R
J Med Virol; 2002 Jun; 67(2):224-33. PubMed ID: 11992583
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors.
Goodfellow IG; Evans DJ; Blom AM; Kerrigan D; Miners JS; Morgan BP; Spiller OB
J Virol; 2005 Sep; 79(18):12016-24. PubMed ID: 16140777
[TBL] [Abstract][Full Text] [Related]
12. Coxsackievirus B3 replication is related to activation of the late extracellular signal-regulated kinase (ERK) signal.
Lim BK; Nam JH; Gil CO; Yun SH; Choi JH; Kim DK; Jeon ES
Virus Res; 2005 Nov; 113(2):153-7. PubMed ID: 15993506
[TBL] [Abstract][Full Text] [Related]
13. Hepatic damage caused by coxsackievirus B3 is dependent on age-related tissue tropisms associated with the coxsackievirus-adenovirus receptor.
Liu JY; Wang SM; Chen IC; Yu CK; Liu CC
Pathog Dis; 2013 Jul; 68(2):52-60. PubMed ID: 23620416
[TBL] [Abstract][Full Text] [Related]
14. Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury.
Dörner A; Grunert HP; Lindig V; Chandrasekharan K; Fechner H; Knowlton KU; Isik A; Pauschinger M; Zeichhardt H; Schultheiss HP
J Mol Med (Berl); 2006 Oct; 84(10):842-51. PubMed ID: 16924471
[TBL] [Abstract][Full Text] [Related]
15. Soluble recombinant coxsackievirus and adenovirus receptor abrogates coxsackievirus b3-mediated pancreatitis and myocarditis in mice.
Yanagawa B; Spiller OB; Proctor DG; Choy J; Luo H; Zhang HM; Suarez A; Yang D; McManus BM
J Infect Dis; 2004 Apr; 189(8):1431-9. PubMed ID: 15073680
[TBL] [Abstract][Full Text] [Related]
16. Stress-activated protein kinases are involved in coxsackievirus B3 viral progeny release.
Si X; Luo H; Morgan A; Zhang J; Wong J; Yuan J; Esfandiarei M; Gao G; Cheung C; McManus BM
J Virol; 2005 Nov; 79(22):13875-81. PubMed ID: 16254323
[TBL] [Abstract][Full Text] [Related]
17. Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor.
He Y; Chipman PR; Howitt J; Bator CM; Whitt MA; Baker TS; Kuhn RJ; Anderson CW; Freimuth P; Rossmann MG
Nat Struct Biol; 2001 Oct; 8(10):874-8. PubMed ID: 11573093
[TBL] [Abstract][Full Text] [Related]
18. Activation of p38 and ERK signaling during adenovirus vector cell entry lead to expression of the C-X-C chemokine IP-10.
Tibbles LA; Spurrell JC; Bowen GP; Liu Q; Lam M; Zaiss AK; Robbins SM; Hollenberg MD; Wickham TJ; Muruve DA
J Virol; 2002 Feb; 76(4):1559-68. PubMed ID: 11799150
[TBL] [Abstract][Full Text] [Related]
19. Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate.
Milstone AM; Petrella J; Sanchez MD; Mahmud M; Whitbeck JC; Bergelson JM
J Virol; 2005 Jan; 79(1):655-60. PubMed ID: 15596863
[TBL] [Abstract][Full Text] [Related]
20. Limited proteolysis of the coxsackievirus and adenovirus receptor (CAR) on HeLa cells exposed to trypsin.
Carson SD
FEBS Lett; 2000 Nov; 484(2):149-52. PubMed ID: 11068050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
